 |
Anadys Pharma kick starts phase I trial of ANA975 for hepatitis C
Friday, February 04, 2005 11:00 IST
San Diego
ANA975 is an oral prodrug of Anadys' proprietary small molecule compound isatoribine, an agonist of Toll-Like Receptor 7
Read complete story ...
(You will need to login first to read this story.)
|
|
|
